PAMS
BNR

Pictet Asset Management (Switzerland)’s Burning Rock Biotech BNR Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,900
Closed -$876K – 1738
2021
Q3 		$876K Buy
+4,900
New +$1.09M ﹤0.01% 1091

Other funds holding BNR

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s BNR Position: Q4 2021 in Review

Pictet Asset Management (Switzerland) sold out of Burning Rock Biotech (BNR) in Q4 2021, closing a stake of 4,900 shares — an estimated $876K sold.

Pictet Asset Management (Switzerland) first reported a position in BNR in Q3 2021 and held it in 1 quarter. The position peaked at $876K in Q3 2021. 62 funds tracked by Wall St. Rank hold BNR as of Q4 2021.

  • Pictet Asset Management (Switzerland) reported no remaining Burning Rock Biotech position as of Q4 2021 after selling out during the quarter.
  • Pictet Asset Management (Switzerland) sold 4,900 Burning Rock Biotech shares in Q4 2021, an estimated $876K.
  • Pictet Asset Management (Switzerland) first reported a position in Burning Rock Biotech in Q3 2021 and held it in 1 quarter.
  • Pictet Asset Management (Switzerland)'s Burning Rock Biotech position peaked at $876K in Q3 2021.
  • 62 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q4 2021.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q4 2021, filed 10 Feb 2022.